Protein’s Levels in Blood May Mark SSc Patients at Risk of PAH

Protein’s Levels in Blood May Mark SSc Patients at Risk of PAH

297004

Protein’s Levels in Blood May Mark SSc Patients at Risk of PAH

Blood levels of the protein endocan may be a potential biomarker in identifying people with scleroderma who are at risk for pulmonary arterial hypertension (PAH), a study reported. The study, which supported previous findings regarding this protein, was titled “Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension,” and published in the journal Biomedicines. Scleroderma, or systemic sclerosis (SSc), can lead to fibrosis (scarring) in multiple organs, inflammation, and…

You must be logged in to read/download the full post.